SCHEMBL7084615

SCHEMBL7084615

CN(C)/C=C/C(=O)c1ccc(NC(=O)OC(C)(C)C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.52
ALDH1A1 P00352 7/20 0.52
HPGD P15428 2/20 0.52
RAB9A P51151 5/20 0.51
LMNA P02545 5/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2C19 P33261 2/20 0.51
RECQL P46063 2/20 0.51
ALOX12 P18054 1/20 0.51
NPC1 O15118 3/20 0.49
POLB P06746 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HSP90AA1 P07900 1/20 0.49
HTT P42858 2/20 0.48
CYP17A1 P05093 2/20 0.47
NAMPT P43490 1/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7084616 1.00 MAPT (0.52) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL5819746 0.81 L3MBTL1 (0.58) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL5819742 0.81 L3MBTL1 (0.58) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL9106572 0.81 MAPT (0.47) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL9106575 0.81 MAPT (0.47) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL6819065 0.80 HDAC3 (0.41) MAPTALDH1A1HPGDRAB9ACYP1A2
SCHEMBL6819063 0.80 HDAC3 (0.41) MAPTALDH1A1HPGDRAB9ACYP1A2
SCHEMBL6071499 0.79 RAB9A (0.60) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL5821517 0.79 RAB9A (0.60) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL13055402 0.78 CYP17A1 (0.59) ALDH1A1SMN1; SMN2CYP17A1NAMPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0862560-B1 SUBSTITUTED 2-ANILINOPYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS CELLTECH THERAPEUTICS LTD (GB) 2003-04-02 EP disclosed
US-6235746-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATIVE AGENT CELLTECH THERAPEUTICS, LIMITED (GB) 2001-05-22 US disclosed
US-5958935-A Substituted 2-anilinopyrimidines useful as protein kinase inhibitors CELLTECH THERAPEUTICS LIMITED (GB) 1999-09-28 US disclosed